Incyte (INCY) Other Non-Current Assets (2010 - 2026)

Incyte (INCY) posted Other Non-Current Assets of $1.8 million for Q1 2026, down 0.86% on a QoQ basis from $1.9 million in Q4 2025, and down 93.91% year-over-year from $30.2 million in Q1 2025.

Incyte (INCY) Other Non-Current Assets (2010 - 2026) Analysis & Trends

Incyte's Other Non-Current Assets history runs 16 years deep, the most recent figure standing at $1.8 million for Q1 2026.

  • Quarterly Other Non-Current Assets fell 93.91% year-over-year to $1.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.8 million (down 93.91% YoY) and the FY2025 annual result came in at $1.9 million, up 14.18% from the prior year.
  • Other Non-Current Assets was $1.8 million for Q1 2026 at Incyte, down from $1.9 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $81.0 million in Q3 2023 and bottomed at $1.6 million in Q4 2024.
  • A 5-year average of $22.7 million and a median of $23.0 million in 2022 frame the typical range for Other Non-Current Assets.
  • Annual changes were most pronounced in 2023 — Other Non-Current Assets soared 2968.73% — and 2024, when it plunged 97.85%.
  • Incyte's Other Non-Current Assets stood at $1.7 million in 2022, then surged by 2968.73% to $52.1 million in 2023, then tumbled by 96.89% to $1.6 million in 2024, then rose by 14.18% to $1.9 million in 2025, then declined by 0.86% to $1.8 million in 2026.
  • Business Quant data shows INCY's Other Non-Current Assets at $1.8 million in Q1 2026, $1.9 million in Q4 2025, and $32.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 1.02 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 104.24 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.26 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 2.13 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 289.41 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 124.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 14.48 Mn
10 Incyte 23.33 Bn 19.32 Bn 1.17 Bn 1.84 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.84 Mn
Dec 31, 2025 1.85 Mn
Sep 30, 2025 32.30 Mn
Jun 30, 2025 32.55 Mn
Mar 31, 2025 30.15 Mn
Dec 31, 2024 1.62 Mn
Sep 30, 2024 1.74 Mn
Jun 30, 2024 1.63 Mn
Mar 31, 2024 47.40 Mn
Dec 31, 2023 52.11 Mn
Sep 30, 2023 80.96 Mn
Jun 30, 2023 1.72 Mn
Mar 31, 2023 20.72 Mn
Dec 31, 2022 1.70 Mn
Sep 30, 2022 23.67 Mn
Jun 30, 2022 23.01 Mn
Mar 31, 2022 31.42 Mn
Dec 31, 2021 1.72 Mn
Sep 30, 2021 24.79 Mn
Jun 30, 2021 20.45 Mn